- active not recruitingPHASE1, PHASE2
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
This study is looking at new drug combinations for advanced cancers like ovarian, breast, lung, and stomach cancer. It checks how safe and effective they are, and how they work in the body.
United States · France · Israel - authorisedPhase II and Phase III (Integrated)
The SURF trial: Optimizing Surgical excision Using Real-time Fluorescence imaging with indocyanine green
The SURF trial is testing a new way to help surgeons find and remove all cancer during an operation. It uses a special dye that glows, helping doctors see cancer cells more clearly. This aims to improve surgery outcomes for various cancer types.
Netherlands